Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β
- PMID: 23160153
- PMCID: PMC3721324
- DOI: 10.1038/ni.2474
Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β
Abstract
Interleukin 1 (IL-1) is an important mediator of innate immunity but can also promote inflammatory tissue damage. During chronic infections such as tuberculosis, the beneficial antimicrobial role of IL-1 must be balanced with the need to prevent immunopathology. By exogenously controlling the replication of Mycobacterium tuberculosis in vivo, we obviated the requirement for antimicrobial immunity and discovered that both IL-1 production and infection-induced immunopathology were suppressed by lymphocyte-derived interferon-γ (IFN-γ). This effect was mediated by nitric oxide (NO), which we found specifically inhibited assembly of the NLRP3 inflammasome via thiol nitrosylation. Our data indicate that the NO produced as a result of adaptive immunity is indispensable in modulating the destructive innate inflammatory responses elicited during persistent infections.
Figures
Comment in
-
Inflammasome: Turning on and off NLRP3.Nat Rev Immunol. 2013 Jan;13(1):1. doi: 10.1038/nri3366. Epub 2012 Nov 30. Nat Rev Immunol. 2013. PMID: 23197112 No abstract available.
-
Just say NO to NLRP3.Nat Immunol. 2013 Jan;14(1):12-4. doi: 10.1038/ni.2493. Nat Immunol. 2013. PMID: 23238751 No abstract available.
References
-
- Lamkanfi M, Dixit VM. Inflammasomes: guardians of cytosolic sanctity. Immunol Rev. 2009;227:95–105. - PubMed
-
- Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519–550. - PubMed
-
- Dinarello CA. Role of interleukin-1 in infectious diseases. Immunol Rev. 1992;127:119–146. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
